These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 15102929

  • 1. Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system.
    Wilhelm CJ, Johnson RA, Lysko PG, Eshleman AJ, Janowsky A.
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1142-51. PubMed ID: 15102929
    [Abstract] [Full Text] [Related]

  • 2. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
    Eyerman DJ, Yamamoto BK.
    J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
    [Abstract] [Full Text] [Related]

  • 3. Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.
    Teng L, Crooks PA, Dwoskin LP.
    J Neurochem; 1998 Jul; 71(1):258-65. PubMed ID: 9648873
    [Abstract] [Full Text] [Related]

  • 4. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
    Gnegy ME, Khoshbouei H, Berg KA, Javitch JA, Clarke WP, Zhang M, Galli A.
    Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305
    [Abstract] [Full Text] [Related]

  • 5. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.
    Brown JM, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
    Pifl C, Drobny H, Reither H, Hornykiewicz O, Singer EA.
    Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
    [Abstract] [Full Text] [Related]

  • 7. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
    Miller DK, Crooks PA, Zheng G, Grinevich VP, Norrholm SD, Dwoskin LP.
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1035-45. PubMed ID: 15121762
    [Abstract] [Full Text] [Related]

  • 8. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB, McConkey F, Liu F, Man HY, Lee FJ, Wang YT, Niznik HB.
    Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
    [Abstract] [Full Text] [Related]

  • 9. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.
    Wilson JM, Levey AI, Bergeron C, Kalasinsky K, Ang L, Peretti F, Adams VI, Smialek J, Anderson WR, Shannak K, Deck J, Niznik HB, Kish SJ.
    Ann Neurol; 1996 Sep; 40(3):428-39. PubMed ID: 8797532
    [Abstract] [Full Text] [Related]

  • 10. [3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.
    Johnson RA, Eshleman AJ, Meyers T, Neve KA, Janowsky A.
    Synapse; 1998 Sep; 30(1):97-106. PubMed ID: 9704886
    [Abstract] [Full Text] [Related]

  • 11. Hydrogen ion concentration differentiates effects of methamphetamine and dopamine on transporter-mediated efflux.
    Wilhelm CJ, Johnson RA, Eshleman AJ, Janowsky A.
    J Neurochem; 2006 Feb; 96(4):1149-59. PubMed ID: 16417578
    [Abstract] [Full Text] [Related]

  • 12. Dopamine stimulation of cardiac beta-adrenoceptors: the involvement of sympathetic amine transporters and the effect of SKF38393.
    Habuchi Y, Tanaka H, Nishio M, Yamamoto T, Komori T, Morikawa J, Yoshimura M.
    Br J Pharmacol; 1997 Dec; 122(8):1669-78. PubMed ID: 9422813
    [Abstract] [Full Text] [Related]

  • 13. Dopamine transporter mediated release of dopamine: role of chloride.
    Sitges M, Reyes A, Chiu LM.
    J Neurosci Res; 1994 Sep 01; 39(1):11-22. PubMed ID: 7807588
    [Abstract] [Full Text] [Related]

  • 14. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
    Teng L, Crooks PA, Sonsalla PK, Dwoskin LP.
    J Pharmacol Exp Ther; 1997 Mar 01; 280(3):1432-44. PubMed ID: 9067333
    [Abstract] [Full Text] [Related]

  • 15. Lobeline inhibits the neurochemical and behavioral effects of amphetamine.
    Miller DK, Crooks PA, Teng L, Witkin JM, Munzar P, Goldberg SR, Acri JB, Dwoskin LP.
    J Pharmacol Exp Ther; 2001 Mar 01; 296(3):1023-34. PubMed ID: 11181937
    [Abstract] [Full Text] [Related]

  • 16. Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.
    Nickell JR, Krishnamurthy S, Norrholm S, Deaciuc G, Siripurapu KB, Zheng G, Crooks PA, Dwoskin LP.
    J Pharmacol Exp Ther; 2010 Feb 01; 332(2):612-21. PubMed ID: 19855096
    [Abstract] [Full Text] [Related]

  • 17. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.
    Wersinger C, Vernier P, Sidhu A.
    Biochemistry; 2004 Feb 10; 43(5):1242-53. PubMed ID: 14756560
    [Abstract] [Full Text] [Related]

  • 18. Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors.
    Brown JM, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2001 Sep 10; 298(3):1150-3. PubMed ID: 11504813
    [Abstract] [Full Text] [Related]

  • 19. Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice.
    Willett MC, Dluzen DE.
    Brain Res; 2004 Dec 17; 1029(2):186-94. PubMed ID: 15542073
    [Abstract] [Full Text] [Related]

  • 20. Lobeline effects on tonic and methamphetamine-induced dopamine release.
    Wilhelm CJ, Johnson RA, Eshleman AJ, Janowsky A.
    Biochem Pharmacol; 2008 Mar 15; 75(6):1411-5. PubMed ID: 18191815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.